6.10
-0.35(-5.43%)
Currency In USD
| Previous Close | 6.45 |
| Open | 6.45 |
| Day High | 6.45 |
| Day Low | 6.1 |
| 52-Week High | 29.4 |
| 52-Week Low | 3 |
| Volume | 64,206 |
| Average Volume | 358,805 |
| Market Cap | 41.09M |
| PE | -0.56 |
| EPS | -10.84 |
| Moving Average 50 Days | 4.41 |
| Moving Average 200 Days | 7.1 |
| Change | -0.35 |
If you invested $1000 in Generation Bio Co. (GBIO) since IPO date, it would be worth $24.71 as of August 26, 2025 at a share price of $6.1. Whereas If you bought $1000 worth of Generation Bio Co. (GBIO) shares 3 years ago, it would be worth $115.31 as of August 26, 2025 at a share price of $6.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire Inc.
Aug 12, 2025 8:05 PM GMT
• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T c
Generation Bio Announces 1-for-10 Reverse Stock Split
GlobeNewswire Inc.
Jul 18, 2025 12:35 PM GMT
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-fo
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jul 07, 2025 8:05 PM GMT
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the com